How can the varied tumour FFPE blocks with HER2 ultra-low influenced on the accurate diagnosis of HER2 in breast cancer

被引：0
|
作者：
Liu, Y. [1 ]
Li, J. [1 ]
Liu, H. [1 ]
Ding, Y. [1 ]
Wu, S. [1 ]
Shang, J. [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-01-001
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [31] HER2 Signaling in Breast Cancer
    Shin, Incheol
    TRANSLATIONAL RESEARCH IN BREAST CANCER, 2021, 1187 : 53 - 79
  • [32] HER2 assessment in breast cancer
    Sapino, Anna
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S30 - S31
  • [33] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    CANCER RESEARCH, 2023, 83 (05)
  • [34] HER2 heterogeneity in breast cancer
    Sala, Elena
    Saccheri, Fabiana
    Crosti, Francesca
    Villa, Nicoletta
    Gautiero, Eugenio
    Brenna, Ambrogio
    Dalpra, Leda
    CHROMOSOME RESEARCH, 2013, 21 : S112 - S112
  • [35] Prognostic difference between early breast cancer patients with HER2 low and HER2 zero status
    Cha, Chihwan David
    Kim, Kyung Eun
    Kim, Jungbin
    Um, Eunhae
    Choi, Nayeon
    Lee, Jungsun
    Gwak, Geumhee
    Kim, Jae Il
    Chung, Min Sung
    NPJ BREAST CANCER, 2025, 11 (01)
  • [36] Prognostic factors in nonmetastatic HER2 'low' & HER2 'negative' breast cancer: Single institute experience
    Turkel, A.
    Dogan, M.
    Sertesen, E.
    Karacin, C.
    Irkkan, S. C.
    Ates, O.
    ANNALS OF ONCOLOGY, 2023, 34 : S299 - S300
  • [37] Reassessment of HER2 status in HER2 negative or HER2 unknown breast cancer patients with recurrent metastatic disease by analyzing serum HER2 and HER2 status of circulating tumor cells.
    Fehm, T.
    Lane, N.
    Solomayer, E.
    Wallwiener, D.
    Uhr, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [38] Improving HER2 testing reproducibility in HER2-low breast cancer
    Sajjadi, Elham
    Venetis, Konstantinos
    Ivanova, Mariia
    Fusco, Nicola
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 882 - 888
  • [39] HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX
    Tozbikian, Gary H.
    Zynger, Debra L.
    BREAST JOURNAL, 2018, 24 (04): : 535 - 540
  • [40] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
12345